Barriers and facilitators to cervical precancer treatment adherence among women in Harare, Zimbabwe: A qualitative study
In the authors' words
Adherence to recommended treatment after a positive cervical screening result remains suboptimal in Zimbabwe. This study explored how women interpreted a cervical precancer diagnosis and how emotional, interpersonal, economic, and health-system factors shaped treatment decisions. We conducted semi-structured in-depth interviews with 25 purposively selected women aged 25-50 years who had screened positive by visual inspection with acetic acid and were recommended for ablative or excisional treatment at two high-volume clinics in Harare. The qualitative component drew on the Health Belief Model and a phenomenological orientation to lived experience. Data were examined using combined deductive and inductive thematic analysis. Three interrelated themes were identified. First, women initially interpreted precancer through fear, shock, and uncertainty; misconceptions that precancer meant invasive cancer, infertility, or imminent death could delay action, whereas clear counselling reframed the diagnosis as treatable. Second, multilevel conditions shaped adherence. Supportive health workers, partner or family encouragement, prior awareness, and connection to HIV services facilitated treatment, while indirect costs, transport, fragmented referral pathways, scheduled excisional services, inconsistent communication, partner opposition, and sexual coercion impeded care. Third, Health Belief Model constructs operated in both directions: perceived severity motivated action when paired with credible benefits and self-efficacy, but produced avoidance when amplified by misinformation and weak support. Improving treatment completion will require standardised counselling, reliable navigation and follow-up, more accessible excisional services, and interventions that address partner dynamics and indirect costs. Screening scale-up should be matched by timely treatment capacity so that women with positive results complete the prevention pathway.
Appeared: Tuesday, November 17. medRxiv. Preprint, not yet peer-reviewed.